However, the 16α-hydroxy-derivatives of estrogens serve as ERα agonists, whereas their 2-hydroxy- and 4-hydroxy-derivatives along with methoxy-derivatives and conjugated estrogens exhibit tumor protective activities. This evidence concerns the gene ESR1 and neoplasm.